title: [Long-term efficacy of transhiatal esophagectomy for esophageal carcinoma and esophagogastric junction cancer].
abstract: OBJECTIVE
  To evaluate the long-term efficacy of transhiatal esophagectomy (THE) for esophageal carcinoma or esophagogastric junction cancer.
  
  
  METHODS
  Between March 2000 and December 2009, a total of 544 patients with either esophageal carcinoma or esophagogastric junction cancer underwent esophagectomy via THE (n=63) or other approaches (n=481) in Beijing cancer hospital institution. Procedures were performed by a single surgeon team. Long-term survival was compared between two groups.
  
  
  RESULTS
  The 1-year, 3-year, 5-year, and 8-year accumulative survival rates in THE group were 91.0%, 60.5%, 44.6%, and 44.6%, respectively, while those in non-THE group were 84.5%, 49.2%, 37.2%, and 28.7%, respectively. The THE group showed better long-term survival than the non-THE group, however the difference was not statistically significant.
  
  
  CONCLUSIONS
  THE is a safe alternative for esophageal carcinoma and esophagogastric junction cancer.
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Thoracic Surgery I, Beijing Cancer Hospital, Peking University School of Oncology, Beijing 100142, China. chenkeneng@yahoo.com.cn
authors.forename: Ke-neng
authors.initials: KN
authors.lastname: Chen
authors.forename: Shao-hua
authors.initials: SH
authors.lastname: Ma
authors.forename: Zhen
authors.initials: Z
authors.lastname: Liang
authors.forename: Xiao-zheng
authors.initials: XZ
authors.lastname: Kang
mesh_terms: D002277:Carcinoma / Q000601:surgery*; D004938:Esophageal Neoplasms / Q000601:surgery*; D016629:Esophagectomy / Q000379:methods*; D004943:Esophagogastric Junction / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome